The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 27, 2021
Filed:
Sep. 17, 2019
Applicant:
Impax Laboratories, Llc, Bridgewater, NJ (US);
Inventors:
Ann Hsu, Hayward, CA (US);
Liang Dong, Hayward, CA (US);
Amy Ding, Hayward, CA (US);
Suneel Gupta, Hayward, CA (US);
Assignee:
Impax Laboratories, LLC, Bridgewater, NJ (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/48 (2006.01); A61K 9/00 (2006.01); A61K 45/06 (2006.01); A61K 9/16 (2006.01); A61K 9/50 (2006.01); A61K 31/198 (2006.01); A61K 31/216 (2006.01);
U.S. Cl.
CPC ...
A61K 9/4808 (2013.01); A61K 9/0053 (2013.01); A61K 9/1652 (2013.01); A61K 9/5026 (2013.01); A61K 9/5042 (2013.01); A61K 9/5073 (2013.01); A61K 31/198 (2013.01); A61K 31/216 (2013.01); A61K 45/06 (2013.01); Y02A 50/30 (2018.01);
Abstract
The invention provides a controlled release oral solid formulation comprising (a) a controlled release component comprising core comprising levodopa and/or an ester of levodopa or salts thereof, wherein the core is coated with a layer of a muco-adhesive polymer and externally coated with a layer of an enteric coated polymer; and (b) a decarboxylase inhibitor component.